How to Source Typhoid Vaccine (Vi Polysaccharide and Conjugate) for Pharmaceutical Formulation
Typhoid Vaccine (Vi Polysaccharide and Conjugate) (Injectable suspension (IM), Capsules (oral, live attenuated), 0.5 mL) is classified under Vaccines. It is therapeutically aligned with reference brands such as Typhim Vi. Vivotif (US). This guide highlights key sourcing factors buyers should consider when procuring high-quality Typhoid Vaccine (Vi Polysaccharide and Conjugate) for formulation, R&D, or bulk manufacturing.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Typhoid Vaccine (Vi Polysaccharide and Conjugate) must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Typhoid Vaccine (Vi Polysaccharide and Conjugate) is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Typhoid Vaccine (Vi Polysaccharide and Conjugate) is more than procurement—it’s a strategic partnership. With its injectable suspension (im), capsules (oral, live attenuated) form and 0.5 mL specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Frequently Asked Questions For Sourcing of Typhoid Vaccine (Vi Polysaccharide and Conjugate)
What is the typical lead time for Typhoid Vaccine (Vi Polysaccharide and Conjugate)?
Lead times range from 4–6 weeks depending on supplier and region.
Is Typhoid Vaccine (Vi Polysaccharide and Conjugate) available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Typhoid Vaccine (Vi Polysaccharide and Conjugate) require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Typhoid Vaccine (Vi Polysaccharide and Conjugate)?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Typhoid Vaccine (Vi Polysaccharide and Conjugate)?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Typhoid Vaccine (Vi Polysaccharide and Conjugate)?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Typhoid Vaccine (Vi Polysaccharide and Conjugate) suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Typhoid Vaccine (Vi Polysaccharide and Conjugate) be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Advertise on PharmaTradZ
Reach verified pharma buyers, suppliers & decision makers worldwide.
Explore Pharma Investment Opportunities
Connect with partners, startups & ventures driving the future of pharma.